Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program -- Project TransMID (NF, PC and NH, Grant Agreement 682540). This project was also funded by the European Union's Horizon 2020 Research and Innovations Programme -- Project EpiPose, Epidemic intelligence to Minimize COVID-19's Public Health, Societal and Economical Impact (NH, grant number 101003688). LW gratefully acknowledges support from the Research Foundation Flanders (FWO) (postdoctoral fellowships 1234620N). NH acknowledges funding from the Antwerp Study Center for Infectious Diseases (ASCID) and the Methusalem-Centre of Excellence consortium VAX-IDEA. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

CoMix social contact data are publicly available at http://www.socialcontactdata.org. PCR tests data are owned by Sciensano, publicly available in aggregate form at https://epistat.wiv-isp.be/covid/ while non-aggregate data can be requested via the online form https://epistat.wiv-isp.be/datarequest.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes